Related Experiment Videos

Relationship of plcR-regulated factors to Bacillus endophthalmitis virulence

Michelle C Callegan1, Scott T Kane, D Clay Cochran

  • 1Department of Ophthalmology, University of Oklahoma Health Sciences Center, Oklahoma City 73104, USA. michellecallegan@ouhsc.edu

Insights

The global regulator plcR significantly impacts Bacillus endophthalmitis severity. Disabling plcR in Bacillus cereus and Bacillus thuringiensis reduces eye inflammation and damage, suggesting plcR as a therapeutic target for preventing blindness.

Area of Science:

  • Ophthalmology
  • Microbiology
  • Infectious Diseases

Background:

  • Bacillus endophthalmitis is a severe ocular infection characterized by rapid destruction.
  • Toxin production by Bacillus species is a key factor in disease pathogenesis.
  • The global regulator plcR controls virulence factors in Bacillus.

Purpose of the Study:

  • To investigate the role of plcR-regulated toxins in the pathogenesis of experimental Bacillus endophthalmitis.
  • To determine if plcR is a viable target for therapeutic intervention.

Main Methods:

  • Construction of isogenic plcR-deficient mutants of Bacillus cereus and Bacillus thuringiensis using insertional inactivation.
  • Intravitreal injection of wild-type or plcR-deficient strains into rabbit eyes.
  • Monitoring of endophthalmitis progression, retinal function, intraocular inflammation, and histological changes.

Main Results:

  • plcR-deficient mutants caused a significantly slower progression of endophthalmitis compared to wild-type strains.
  • Complete loss of retinal function occurred within 18 h with wild-type infections versus 42 h with plcR-deficient infections.
  • Inflammatory cell influx and retinal destruction were attenuated, and anterior/posterior segment changes were less severe in eyes infected with plcR mutants.

Conclusions:

  • The global regulator plcR plays a critical role in the severity of Bacillus endophthalmitis.
  • Loss of plcR-regulated factors significantly attenuates disease progression and ocular damage.
  • Targeting plcR may offer a novel therapeutic strategy for preventing blindness in Bacillus endophthalmitis.

Related Concept Videos